Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, China
Hongbin Ji is a Professor of cancer biology in Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS). He obtained his Ph.D. degree from Shanghai Institute of Biological Sciences, CAS in 2000. He then joined Dr. Cox Terhorst’s lab in Beth Israel Deaconess Medical Center as research associate to study CD3 gene regulation and regulatory T cells in inflammatory bowel disease. In 2004, he joined Dr. Kwok-Kin Wong’s lab in Dana-Farber Cancer Institute to study lung tumorigenesis using animal models. In 2007, he joined the faculty in Shanghai Institute of Biochemistry and Cell Biology, CAS. Dr. Ji has identified the RET-fusion as new oncogenic driver in human lung adenocarcinoma and proven the existence of lung adenocarcinoma-to-squamous cell carcinoma transdifferentiation in mouse. Dr. Ji receives many honors and rewards including National Distinguished Young Scientist.